Purple Biotech (PPBT) EBIAT (2014 - 2026)
Purple Biotech (PPBT) reported EBIAT of $89000.0 for Q1 2026, up 119.52% year-over-year from $40543.5 in Q1 2025, and up 119.52% on a QoQ basis from -$456000.0 in Q1 2025.
Purple Biotech (PPBT) has 2 years of EBIAT data on file, last reported at $89000.0 in Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.99 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14.46 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.03 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.63 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 727.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 205.99 Mn |
| 10 | Purple Biotech | 3.58 Bn | 3.57 Bn | - | 89,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 89,000.00 |
| Dec 31, 2025 | 23.64 Mn |
| Sep 30, 2025 | 1.31 Mn |
| Jun 30, 2025 | 1.09 Mn |
| Mar 31, 2025 | -456,000.00 |
| Dec 31, 2024 | 415,000.00 |
| Sep 30, 2024 | 668,000.00 |
| Jun 30, 2024 | 2.42 Mn |
| Mar 31, 2024 | -3.78 Mn |
| Dec 31, 2023 | 4.86 Mn |
| Sep 30, 2023 | 5.06 Mn |
| Jun 30, 2023 | 5.16 Mn |
| Mar 31, 2023 | 4.90 Mn |
| Dec 31, 2022 | 6.04 Mn |
| Sep 30, 2022 | 4.85 Mn |
| Jun 30, 2022 | 3.55 Mn |
| Mar 31, 2022 | -7.32 Mn |
| Dec 31, 2021 | 5.11 Mn |
| Sep 30, 2021 | 3.15 Mn |
| Jun 30, 2021 | 3.64 Mn |
| Mar 31, 2021 | 6.43 Mn |
| Dec 31, 2020 | -258,000.00 |
| Dec 31, 2019 | -3.29 Mn |
| Dec 31, 2018 | 386,000.00 |
| Dec 31, 2017 | 6.90 Mn |
| Dec 31, 2016 | 12.13 Mn |
| Dec 31, 2015 | 4.20 Mn |
| Sep 30, 2015 | 1.26 Mn |
| Dec 31, 2014 | -9.71 Mn |
| Sep 30, 2014 | 1.24 Mn |